Authors
Loading...
In vitro assay demonstrates that synthetic C2 domain peptides block factor VIII binding to phosphatidylserine, suggesting residues 2303–2332 form a critical phospholipid interaction site.
Foster et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: